Insulin glargine 300 U/mLversus first-generation basal insulin analogues in insulin-naive adults with type 2 diabetes: 12-month outcomes ofACHIEVEControl, a prospective, randomized, pragmatic real-life clinical trial Article
Industry Collaboration
International Collaboration